Filtered By:
Specialty: Pharmaceuticals
Source: Pharmaceutical Technology
Condition: Heart Attack
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Merck's Zontivity gets FDA approval to reduce heart attacks and stroke risk in patients
Merck has received approval from the US Food and Drug Administration (FDA) for Zontivity (vorapaxar) for people at high-risk of heart attack or stroke.
Source: Pharmaceutical Technology - May 13, 2014 Category: Pharmaceuticals Source Type: news
New drug may reduce tissue damage after a heart attack
A chemical compound has been developed to reduce tissue damage following a heart attack, stroke or major surgery.
Source: Pharmaceutical Technology - May 27, 2013 Category: Pharmaceuticals Source Type: news
